Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Gene therapy with adenovirus vector containing the normal CF gene: Began trial to determine safety of delivery by bronchoscope into one lobe of each patient's l

Genzyme Corp. (GENZ), Cambridge, Mass.
Product:

Read the full 61 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE